Short Summary
The PTAB issued a final decision rejecting the petitioner's challenge to claims 1-23 of U.S. Patent No. 10715878. The Board found that the evidence failed to demonstrate unpatentability under 35 U.S.C. § 103, upholding the patent owner’s rights regarding targeted advertising methods.
Detailed Summary
In this final written decision, the Patent Trial and Appeal Board (PTAB) ruled against the petitioners—including Meta Platforms, Roku, and Samsung Electronics Co., Ltd.—who challenged claims 1 through 23 of U.S. Patent No. 10715878. The petitioner asserted obviousness under 35 U.S.C. § 103, arguing that combinations of prior art references (such as Baig, Laidlaw, and Hahn) rendered the targeted advertising claims unpatentable. However, the Board concluded that the patent owner successfully demonstrated that the claims required an affirmative 'determination' within a predetermined time frame, which was not taught or suggested by the cited prior art. Consequently, the petitioner failed to demonstrate unpatentability of any challenged claim.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Samsung Electronics Co., Ltd. et al. vs Intent IQ, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Samsung Electronics Co. Ltd. et al.vsMaxell, Ltd.
Samsung filed an IPR petition against Maxell's patent covering touchscreen/fingerprint authentication technology, asserting obviousness under 35 U.S.C. § 103. The petitioner argues that various combinations of prior art references (Rogers, Rosenberg, Miyazawa, Rekimoto) render the challenged claims unpatentable.
SAMSUNG ELECTRONICS CO., LTD. et al.vsVasu Holdings, LLC
The USPTO Director denied Samsung’s request for review of the PTAB’s institution decisions in multiple IPRs, leaving the original denials in place.
Pinterest, Inc.vsOpenTV, Inc. et al.
Pinterest has filed an IPR petition seeking to invalidate OpenTV’s ’169 Patent claims covering interactive‑TV rendering methods, citing obviousness over five prior‑art references.
Merck Sharp & Dohme LLCvsHalozyme, Inc. et al.
Merck defends its PH20 enzyme patent in a PTAB Director Review proceeding, arguing that the claims satisfy §112 written description and enablement and that Halozyme's claim‑construction objections are unfounded. The petitioner also contends that Fintiv factors do not justify discretionary denial.
iRhythm, Inc.vsWelch Allyn, Inc. et al.
iRhythm Technologies seeks a Director Review to overturn the PTAB Acting Director's discretionary denial of its IPR petitions against Welch Allyn’s wearable cardiac‑monitor patents. The petitioner argues the new "settled expectations" rule was applied retroactively, violates precedent, and harms patent quality.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.